Trending FOX BUSINESS News: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group

Trending FOX BUSINESS News: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group


Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group


If Phase 1 is successful, Novavax will follow up with Phase 2 in multiple countries, including the U.S.

Related Posts

0 Response to "Trending FOX BUSINESS News: Novavax starts Phase 1 coronavirus vaccine trial after $388M from Bill Gates-backed group"

Post a Comment